Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Palladium Catalyzed Asymmetric Allylic Substitution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel biaryl ligand synthesis via Catellani reaction offers high enantioselectivity and scalable routes for pharmaceutical intermediates.
Patent CN111718372B discloses a novel axial chiral ligand enabling high-yield asymmetric allylic substitution with simplified synthesis for cost-effective API manufacturing.
Patent CN111718372B discloses a novel axial chiral ligand enabling high-yield asymmetric allylic substitution with excellent enantioselectivity for cost-effective API manufacturing.
Patent CN111718372B enables high-purity fine chemical production through innovative ligand technology with reduced lead time and scalable manufacturing solutions for pharmaceutical intermediates.